Tilt Investment Management Holdings PBC Cuts Position in Colgate-Palmolive (NYSE:CL)

Tilt Investment Management Holdings PBC trimmed its position in shares of Colgate-Palmolive (NYSE:CL) by 23.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,362 shares of the company’s stock after selling 1,018 shares during the period. Tilt Investment Management Holdings PBC’s holdings in Colgate-Palmolive were worth $268,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. OFI Invest Asset Management purchased a new position in Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth increased its stake in Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $34,000. Quarry LP increased its stake in Colgate-Palmolive by 48.2% in the second quarter. Quarry LP now owns 446 shares of the company’s stock valued at $34,000 after purchasing an additional 145 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its holdings in Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Evercore ISI raised their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Wells Fargo & Company raised their target price on Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a report on Monday, January 29th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 price objective for the company. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research report on Monday, January 29th. Finally, UBS Group lifted their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $86.30 on Friday. The stock’s 50 day moving average price is $87.02 and its 200 day moving average price is $80.67. The firm has a market capitalization of $70.94 billion, a PE ratio of 31.19, a price-to-earnings-growth ratio of 3.26 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. Colgate-Palmolive’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.77 EPS. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is presently 69.06%.

Insider Buying and Selling at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock valued at $19,505,099 in the last three months. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.